Welcome to LookChem.com Sign In|Join Free
  • or
4-(3-BROMOPHENYL)-4-OXOBUTYRIC ACID is a chemical compound with the molecular formula C10H9BrO3. It is a derivative of butyric acid, a common fatty acid found in milk and animal fats. 4-(3-BROMOPHENYL)-4-OXOBUTYRIC ACID features a bromine atom attached to a phenyl ring and a ketone group at the fourth carbon of the butyric acid chain. Its unique structure and properties may offer potential applications in organic synthesis and pharmaceuticals.
Used in Organic Synthesis:
4-(3-BROMOPHENYL)-4-OXOBUTYRIC ACID is used as a building block for the synthesis of various organic compounds. Its bromine atom and ketone group provide opportunities for further chemical reactions, making it a versatile intermediate in the creation of new molecules.
Used in Pharmaceutical Industry:
4-(3-BROMOPHENYL)-4-OXOBUTYRIC ACID is used as a starting material for the development of pharmaceutical drugs. Its unique structure may contribute to the design of new drugs with specific therapeutic properties, potentially leading to advancements in medicine.
Used in Chemical Research:
4-(3-BROMOPHENYL)-4-OXOBUTYRIC ACID is used as a research compound to study its chemical properties and reactivity. Understanding its behavior in various reactions can provide insights into the development of new synthetic methods and applications in the chemical sciences.

62903-13-3

Post Buying Request

62903-13-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

62903-13-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 62903-13-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,9,0 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 62903-13:
(7*6)+(6*2)+(5*9)+(4*0)+(3*3)+(2*1)+(1*3)=113
113 % 10 = 3
So 62903-13-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H9BrO3/c11-8-3-1-2-7(6-8)9(12)4-5-10(13)14/h1-3,6H,4-5H2,(H,13,14)

62903-13-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(3-bromophenyl)-4-oxobutanoic acid

1.2 Other means of identification

Product number -
Other names 4-(3'-bromophenyl)-4-oxo-butanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:62903-13-3 SDS

62903-13-3Relevant academic research and scientific papers

Highly enantioselective [3+2] coupling of cyclic enamides with quinone monoimines promoted by a chiral phosphoric acid

Zhang, Minmin,Yu, Shuowen,Hu, Fangzhi,Liao, Yijun,Liao, Lihua,Xu, Xiaoying,Yuan, Weicheng,Zhang, Xiaomei

supporting information, p. 8757 - 8760 (2016/07/15)

Enantioselective [3+2] coupling of cyclic enamides with quinone monoimines was realised using a chiral phosphoric acid as a catalyst. This transformation allowed for the synthesis of highly enantioenriched polycyclic 2,3-dihydrobenzofurans (up to 99.9% ee). The absolute configuration of one product was determined by an X-ray crystal structural analysis. We also found a possible mechanism for this reaction.

4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity

-

, (2008/06/13)

4-phenyl-4-oxo-butanoic acid derivatives for use in the treatment of the human or animal body by therepy; particularly as kynurenine-3-hydroxylase inhibitors, in the prevention and/or treatment of a neurodegenerative disease wherein the inhibition of such an enyzme is needed. The present invention further comprises a selected class of the above mentioned 4-phenyl-4-oxo-butanoic acid derivatives, their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 62903-13-3